Stryker | SYK - Bruttoergebnis Vom Umsatz

Aktienkurs
299.02
Täglich Wechseln
-16.11 -5.11%
Monatlich
-9.81%
Jährlich
-20.94%
Q2 Prognose
320.50




Bruttoergebnis Vom Umsatz Veränderung Datum
Abbott USD 5.86B 675M 2026-03
AtriCure USD 105.34M 4M 2025-12
Avanos Medical USD 86M 0 2025-12
Baxter International USD 891M 314M 2026-03
Becton, Dickinson and Co. USD 2.41B 1.72B 2025-12
Boston Scientific USD 3.61B 64M 2026-03
CONMED USD 183.45M 34.84M 2026-03
Cooper Companies USD 695.2M 44.4M 2025-12
Danaher USD 3.59B 375M 2026-03
Dexcom USD 750.3M 42.4M 2026-03
Edwards Lifesciences USD 1.29B 59.4M 2026-03
Globus Medical USD 535.95M 49.28M 2025-12
Haemonetics USD 202.39M 7.64M 2025-12
Insulet USD 568.6M 58.5M 2025-12
Integra LifeSciences USD 217.1M 10.11M 2025-12
Intuitive Surgical USD 1.83B 73.8M 2026-03
J&J USD 17.24B 642M 2026-03
Masimo USD 247.3M 16.7M 2025-12
Medtronic USD 5.41B 27M 2025-12
Merit Medical Systems USD 184.8M 10.56M 2026-03
Olympus JPY 164.9B 3.6B 2025-12
Smith & Nephew USD 2.09B 117M 2025-12
Steris USD 655.5M 9.6M 2025-12
Stryker USD 3.81B 675M 2026-03
Tandem Diabetes Care USD 167.46M 33.17M 2025-12
Teleflex USD 307.45M 144.2M 2025-12
Terumo JPY 153.19B 6.2B 2025-12
Zimmer Biomet Holdings USD 1.27B 8.1M 2025-12